Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) shares, rose in value, with the stock price up by 0.09% to the previous day’s close as strong demand from buyers drove the stock to $9.97.
Actively observing the price movement in the recent trading, the stock is buoying the session at $9.96, falling within a range of $9.92 and $10.075. The value of beta (5-year monthly) is 1.103. Referring to stock’s 52-week performance, its high was $11.31, and the low was $5.92. On the whole, BCRX has fluctuated by -3.50% over the past month.
With the market capitalization of Biocryst Pharmaceuticals Inc currently standing at about $2.09 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-05.
The stock’s technical analysis shows that the price of BCRX currently trading nearly -6.23% and 4.36% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.74, while the 7-day volatility ratio is showing 1.41% which for the 30-day chart, stands at 2.14%. Furthermore, Biocryst Pharmaceuticals Inc (BCRX)’s beta value is 1.10, and its average true range (ATR) is 0.38.
A comparison of Biocryst Pharmaceuticals Inc (BCRX) with its peers suggests the former has fared considerably weaker in the market. BCRX showed an intraday change of 0.09% in today’s session so far, and over the past year, it grew by 59.76%%.
Data on historical trading for Biocryst Pharmaceuticals Inc (NASDAQ:BCRX) indicates that the trading volumes over the past 10 days have averaged 3.29 and over the past 3 months, they’ve averaged 4.48 million. According to company’s latest data on outstanding shares, there are 209.21 million shares outstanding.
Nearly 4.19% of Biocryst Pharmaceuticals Inc’s shares belong to company insiders and institutional investors own 84.28% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 24.02 million shares as on 2025-05-30, resulting in a short ratio of 3.62. According to the data, the short interest in Biocryst Pharmaceuticals Inc (BCRX) stood at 1153.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 18.3 million. The stock has risen by 32.56% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BCRX stock heading into the next quarter.
